We hypothesis that the other tick-borne pathogens are pathogenic and cause significant clinical disease in the Netherlands
ID
Bron
Verkorte titel
Aandoening
Lyme borreliosis, anaplasmosis, babesiosis, Borrelia miyamotoi disease, neoehrlichiosis, rickettsiosis, tick-borne encephalitis virus
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The primary outcome measures the prevalence of the different TBDs tested in blood, urine, skin biopsy in a group of participants who develop fever within 4 weeks after tick-bite in the Netherlands, of whom other causes of the fever are excluded. This measurement will be compared to the prevalence of infection with the same TBPs between the different control groups.
Achtergrond van het onderzoek
The study is designed as a prospective case-control study. We aim to include 150 cases and 3 control groups consisting of 200 tick-bite, 200 general population and 200 healthy blood donor controls. During a one year follow-up we will acquire bodily materials – such as blood, urine and skin biopsy samples – ticks and questionnaires. The study investigates how often the TBPs Anaplasma phagocytophilum, Babesia species, Borrelia miyamotoi, Neoehrlichia mikurensis, Rickettsia species and tick-borne encephalitis (TBEV) can cause an acute febrile illness after tick-bite besides LB. We aim to determine the impact and seriousness of other tick-borne diseases (TBDs) in the Netherlands by measuring the prevalence and describing the clinical picture and the course of different other TBDs. In addition, the obtained materials will be used to develop diagnostic modalities to detect TBPs.
Doel van het onderzoek
We hypothesis that the other tick-borne pathogens are pathogenic and cause significant clinical disease in the Netherlands
Onderzoeksopzet
Materials: baseline, 4 and 12 weeks
Questionnaires: baseline, 3, 6, 9 and 12 months
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Cases (n=150)
• Subjects are ≥16 years old;
• Subjects report a tick-bite acquired within the last 2 months;
• Subjects report an objectified (measured rectally, orally, axillary or tympanic) fever (defined as ≥38.0°C) within the last 4 weeks, developed in the course of 4 weeks after tick-bite;
• Subjects live or stay in the Netherlands during the course of the study.
Controls (n=200)
• Subjects are ≥16 years old;
• Subjects report a tick-bite acquired within the last 2 months;
• Subjects frequency match to cases by gender, age, province of residence and month of tick-bite acquirement;
• Subjects live or stay in the Netherlands during the course of the study.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Cases
• Subjects with evident signs or symptoms of another cause of the fever besides a TBD;
• Subjects unable to provide informed consent or do not have sufficient proficiency in the Dutch language.
Controls
• Subjects develop an objectified (measured rectally, orally, axillary or tympanic) temperature >37.3°C within 4 weeks after the tick-bite;
• Subjects with evident signs or symptoms of a currant infectious disease;
• Subjects unable to provide informed consent or do not have sufficient proficiency in the Dutch language.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL9258 |
| Ander register | METC AMC : 2017_904 |